AIG
SYRS

American International Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

American International Group’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,858
Closed -$34K – 3299
2022
Q1 		$34K Sell
2,858
-201
-7% -$3.6K ﹤0.01% 2954
2021
Q4 		$100K Sell
3,059
-92
-3% -$3.73K ﹤0.01% 2716
2021
Q3 		$141K Sell
3,151
-75
-2% -$3.66K ﹤0.01% 2634
2021
Q2 		$176 Buy
3,226
+476
+17% +$28.2K ﹤0.01% 2592
2021
Q1 		$206 Buy
2,750
+337
+14% +$35K ﹤0.01% 2354
2020
Q4 		$262 Sell
2,413
-70
-3% -$6.39K ﹤0.01% 2136
2020
Q3 		$220K Sell
2,483
-56
-2% -$6.36K ﹤0.01% 2093
2020
Q2 		$271K Buy
2,539
+488
+24% +$43.8K ﹤0.01% 1955
2020
Q1 		$122K Sell
2,051
-119
-5% -$8.07K ﹤0.01% 2198
2019
Q4 		$150K Sell
2,170
-18
-0.8% -$1.09K ﹤0.01% 2386
2019
Q3 		$227K Sell
2,188
-15
-0.7% -$1.42K ﹤0.01% 2090
2019
Q2 		$204K Buy
2,203
+590
+37% +$41.1K ﹤0.01% 2218
2019
Q1 		$147K Sell
1,613
-53
-3% -$3.69K ﹤0.01% 2383
2018
Q4 		$93K Sell
1,666
-12
-0.7% -$912 ﹤0.01% 2636
2018
Q3 		$200K Buy
1,678
+83
+5% +$9.63K ﹤0.01% 2420
2018
Q2 		$163K Buy
1,595
+607
+61% +$75.2K ﹤0.01% 2488
2018
Q1 		$128K Buy
988
+145
+17% +$15.9K ﹤0.01% 2526
2017
Q4 		$82K Buy
843
+4
+0.5% +$537 ﹤0.01% 2809
2017
Q3 		$123K Buy
839
+63
+8% +$11.8K ﹤0.01% 2542
2017
Q2 		$125K Buy
776
+489
+170% +$76.8K ﹤0.01% 2589
2017
Q1 		$46K Buy
+287
New +$35K ﹤0.01% 2859

Other funds holding SYRS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American International Group's SYRS Position: Q2 2022 in Review

American International Group sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2022, closing a stake of 2,858 shares — an estimated $34K sold.

American International Group first reported a position in SYRS in Q1 2017 and held it in 21 quarters. The position peaked at $271K in Q2 2020. 67 funds tracked by Wall St. Rank hold SYRS as of Q2 2022.

  • American International Group reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 2,858 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $34K.
  • American International Group first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 21 quarters.
  • American International Group's Syros Pharmaceuticals, Inc. Common Stock position peaked at $271K in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.